| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.065 | 0.1 |